Are we consuming enough long chain omega-3 polyunsaturated fatty acids for optimal health?

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 85, Issue 5, 2011, Pages 275-280

  Meyer, B J ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; LONG CHAIN FATTY ACID; OMEGA 3 FATTY ACID;

ARTICLE; CARDIOVASCULAR DISEASE; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG EFFECT; FISH; FOOD INTAKE; GEOGRAPHIC DISTRIBUTION; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MEAT; NUTRITIONAL ASSESSMENT; NUTRITIONAL HEALTH; NUTRITIONAL REQUIREMENT; PRIORITY JOURNAL; SEA FOOD;

AUSTRALIA; CARDIOVASCULAR DISEASES; FATTY ACIDS, OMEGA-3; HUMANS; JAPAN; SEAFOOD;

EID: 80053350340     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2011.04.010     Document Type: Article

References (79)

1. Connor W.E. Importance of n-3 fatty acids in health and disease. Am. J. Clin. Nutr. 2000, 71:171-175.
2. Siscovick D.S., Raghunathan T.E., King I., et al. Dietary-intake and cell-membrane levels of long-chain n-3 polyunsaturated fatty-acids and the risk of primary cardiac-arrest. J. Am. Med. Assoc. 1995, 274:1363-1367.
3. de Lorgeril M., Salen P., Martin J.L., Monjaud I., Delaye J., Mamelle N. Mediterranean diet, traditional risk factors and the rate of cardiovascular complications after myocardial infarction-final report of the Lyon diet heart study. Circulation 1999, 99:779-785.
4. GISSI-Prevenzione Investigators Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Pevenzione trial. Lancet 1999, 354:447-455.
5. Simopoulos A.P. Essential fatty acids in health and chronic disease. Am. J. Clin. Nutr. 1999, 70(Suppl. 3):560-569.
6. von Schacky C., Angerer P., Kothny W., Theisen K., Mudra H. The effect of dietary omega-3 fatty acids on coronary atherosclerosis-a randomised, double-blind, placebo-controlled trial. Ann. Int. Med. 1999, 130:554-562.
7. McLennan W., Podger A. National Nutrition Survey, Selected Highlights 1997, Australian Government Publishing Service, Canberra, Australia.
8. Meyer B.J., Mann N.J., Lewis J.L., Milligan G.C., Sinclair A.J., Howe P.R.C. Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids. Lipids 2003, 38:391-398.
9. Howe P., Buckley J., Meyer B. Long-chain omega-3 fatty acids in red meat. Nutr. Diet. 2007, 64(Suppl. 4):S135-S139.
10. Williams P.G. Nutritional composition of red meat. Nutr. Diet. 2007, 64(Suppl 4):S113-S119.
11. Howe P., Meyer B., Record S., Baghurst K. Dietary intake of long-chain n-3 polyunsaturated fatty acids: contribution of meat sources. Nutrition 2006, 22:47-53.
12. Commonwealth of Australia, 2007 Australian National Children's Nutrition and Physical Activity Survey-Main findings, Commonwealth of Australia, Canberra, 2008.
13. B.J. Meyer, N. Kolanu, Australian children are not consuming enough long chain omega-3 polyunsaturated fatty acids for optimal health, Nutrition, accepted for publication.
14. Bang H.O., Dyerberg J., Sinclair H.M. The composition of the Eskimo food in north western Greenland. Am. J. Clin. Nutr. 1980, 33:2657-2661.
15. Dewailly E., Blanchet C., Gingras S., Lemieux S., Holub B.J. Fish consumption and blood lipids in three ethnic groups of Quebec (Canada). Lipids 2003, 38:359-365.
16. Sugano M. Characteristics of fats in Japanese diets and current recommendations. Lipids 1996, 31(Suppl.):S283-S286.
17. Hino A., Adachi H., Toyomasu K., et al. Very long chain N-3 fatty acids intake and carotid atherosclerosis. An epidemiological study evaluated by ultrasonography. Atherosclerosis 2004, 176:145-149.
18. Nakamura Y., Ueshima H., Okuda N., et al. For the INTERLIPID Research group. Relation of dietary and other lifestyle traits to difference in serum adiponectin concentrations of Japanese in Japan and Hawaii: the INTERLIPID Study. Am. J. Clin. Nutr. 2008, 88:424-430.
19. Astorg P., Arnault N., Czernichow S., Noisette N., Galan P., Hercberg S. Dietary Intake and food sources of n-6 and n-3 PUFA in French adult men and women. Lipids 2004, 34(6):527-535.
20. Lucas M., Asselin G., Plourde M., Cunnane S.C., Dewailly E., Dodin S. n-3 fatty acid intake from marine food products among Quebeces: comparison to worldwide recommendations. Public Health Nutr. 2010, 13(1):63-70.
21. Augood C., Chakravarthy U., Young I., et al. Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. Am. J. Clin. Nutr. 2008, 88:398-406.
22. Sioen I., Devroe J., Inghels D., Terwecoren R., de Henauw S. The influence of n-3 PUFA supplements and n-3 PUFA enriched foods on the n-3 LC PUFA intake of Flemish women. Lipids 2010, 45:313-320.
23. Bauch A., Lindtner O., Mensink G.B.M., Niemann B. Dietary intake and sources of long chain n-3 PUFA in German adults. Eur. J. Clin. Nutr. 2006, 60:810-812.
24. US Department of Agriculture National Nutrient Database, 2004, USDA 1999. http://www.nal.usda.gov/fnic/foodcomp/search/.
25. He K., Liu K., Daviglus M.L., et al. Intakes of long-chain n-3 polyunsaturated fatty acids and fish in relation to measurements of subclinical atherosclerosis. Am. J. Clin. Nutr. 2008, 88:1111-1118.
26. Heine-Broring R.C., Brouwer I.A., Proenca R.V., et al. Intake of fish and marine n-3 fatty acids in relation to coronary calcification: the Rotterdam Study. Am. J. Clin. Nutr. 2010, 91:1317-1327.
27. Ponnampalam E.N., Mann N.J., Sinclair A.J. Effect of feeding systems on omega-3 fatty acids, conjugated linoleic acid and trans fatty acids in Australian beef cuts: potential impact on human health. Asia Pac. J. Clin. Nutr. 2006, 15:21-29.
28. Rule D.C., Broughton K.S., Shellito S.M., Maiorano G. Comparison of muscle fatty acid profiles and cholesterol concentration of bison, beef cattle, elk and chicken. J. Anim. Sci. 2002, 85(1):1202-1211.
29. Sullivan B.L., Williams P.G., Meyer B.J. Biomarker validation of a long-chain omega-3 polyunsaturated fatty acid food frequency questionnaire. Lipids 2006, 41:845-850.
30. Sullivan B.L., Brown J., Williams P.G., Meyer B.J. Development and dietary validation of a new food frequency questionnaire that estimates long-chain n-3 fatty acid intakes. Br. J. Nutr. 2008, 99:660-666.
31. Swierk M., Williams P.G., Wilcox J., Russell K., Meyer B.J. Validation of an Australian electronic food frequency questionnaire to measure polyunsaturated fatty acid intake. Nutrition 2011, 27:641-646.
32. Chiba N., Okuda N., Okayama A., Kadowaki T., Ueshima H. Development of a food frequency and quantity method for assessing dietary habits of Japanese individuals-comparison with results from 24hr recall dietary survey. J. Atheroscler. Thromb. 2008, 15:324-333.
33. Leclercq C., Arcella D., Piccinella R., Sette S., Le Donne C. A. Turrini on behalf of the INRAN-SCAI 2005-06 Study Group. The Italian national food consumption survey INRAN-SCAI 2005-06: main results in terms of food consumption. Public Health Nutr. 2009, 12(1):2504-2532.
34. Virtanen J.K., Mozaffarian D., Chiuve S.E., Rimm E. Fish consumption and risk of major chronic disease in men. Am. J. Clin. Nutr. 2008, 88:1618-1625.
35. Yamagishi K., Iso H., Date C., et al. Fish, n-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women, The JACC (Japan collaborative cohort study for evaluation of cancer risk) study. J. Am. Coll. Cardiol. 2008, 52:988-996.
36. Martinez M., Mougan I. Fatty acid composition of human brain phospholipids during normal development. J. Neurochem. 1998, 71:2528-2533.
37. Al M.D., van Houwelingen A.C., Kester A.D., Hasaart T.H., de Jong A.E., Hornstra G. Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status. Br. J. Nutr. 1995, 74:55-68.
38. Makrides M., Gibson R.A. Long-chain polyunsaturated fatty acid requirements during pregnancy and lactation. Am. J. Clin. Nutr. 2000, 71:307-311.
39. Koletzko B., Cetin I., Brenna J.T. Consensus statement: dietary fat intakes for pregnant and lactating women. Br. J. Nutr. 2007, 98:873-877.
40. International Society for the Study of Fatty Acids and Lipids, Recommendations for intake of polyunsaturated fatty acids in healthy adults, 2004, http://www.issfal.org.uk.
41. Cosatto V.F., Else P.L., Meyer B.J. Do pregnant women and those at risk of developing post-natal depression consume lower amounts of long chain omega-3 polyunsaturated fatty acids?. Nutrients 2010, 2(2):198-213. 10.3390/nu202019.
42. Sinikovic D., Yeatman H.R., Cameron D., Meyer.B.J. Women's awareness of the importance of long-chain omega-3 polyunsaturated fatty acid consumption during pregnancy: knowledge of risks, benefits and information accessibility. Public Health Nutr. 2009, 12(4):562-569.
43. Hibbeln J.R., Davis J.M., Steer C., et al. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. Lancet 2007, 369:578-585.
44. Demmelmair H., von Schenck U., Behrendt E., Sauerwald T., Koletzko B. Estimation of arachidonic acid synthesis in full term neonates using variation of 13C content. J. Pediatr. Gastroenterol. Nutr. 1995, 21:31-36.
45. Szitanyi P., Koletzko B., Mydlilova A., Demmelmair H. Metabolism of 13C-labeled linoleic acid in newborn infants during the first week of life. Pediatr. Res. 1999, 45:669-673.
46. Vlaardingerbroek H., Hornstra G., de Koning T.J., et al. Essential polyunsaturated fatty acids in plasma and erythrocytes of children with inborn errors of amino acid metabolism. Mol. Genet. Metab. 2006, 88:159-165.
47. Mozzafarian D. JELIS, fish oil and cardiac events. Lancet 2007, 369:1062-1063.
48. Yokoyama M., Origasa H., Matsuzaki M., et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis. Lancet 2007, 369:1090-1098.
49. Harris W.S. n-3 Fatty acids and serum lipoproteins: human studies. Am. J. Clin. Nutr. 1997, 65(Suppl. 5):1645S-1654S.
50. Milte C.M., Coates A.M., Buckley J.D., Hill A.M., Howe P.R.C. Dose-dependent effects of docosahexaenoic acid-rich fish oil on erythrocyte docosahexaenoic acid and blood lipid levels. Br. J. Nutr. 2008, 99:1083-1088.
51. Sparkes C., Sinclair A., Gibson R., Else P., Meyer B. Effective does of omega-3 PUFA for triglyceride lowering in pre-menopausal women. Atheroscler. Suppl. 2009, 10(2):e775. (abstract).
52. Meyer B.J., Hammervold T., Rustan A.C.Hr., Howe P.R.C. Dose dependent effects of DHA supplementation in statin treated hyperlipidaemic subjects. Lipids 2007, 42(2):109-115.
53. Balk E.M., Lichtenstein A.H., Chung M., Kupelnick B., Chew P., Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 2006, 189:19-30.
54. Contacos C., Barter P.J., Sullivan D.R. Effect of pravastatin and omega-3 fatty acids on plasma lipids in patients with combined hyperlipidaemia. Arterio. Thromb. 1993, 13(12):1755-1762.
55. Mori T.A., Burke V., Puddey I.B., et al. Purified eicosapentaenoic acid and docosahexaenoic acid have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am. J. Clin. Nutr. 2000, 71(5):1085-1094.
56. Suzukawa M., Abbey M., Howe P.R., Nestel P.J. Effect of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. J. Lipid Res. 1995, 36(3):473-484.
57. Thomas T.R., Smith B.K., Donahue A.M., Altena T.S., James-Kracke M., Sun G.Y. Effects of omega-3 fatty acid supplementation and exercise on low density lipoprotein and high density lipoprotein subfractions. Metabolism 2004, 53(6):749-754.
58. Mori T.A. Omega-3 fatty acids and hypertension in humans. Clin. Exp. Pharmacol. Physiol. 2006, 33:842-846.
59. Meyer B.J., Lane A.E., Mann N.J. Comparison of seal oil and tuna oil on plasma lipid levels and blood pressure in hypertriglyceridaemic subjects. Lipids 2009, 44:827-835.
60. Vericel E., Calzada C., Chapuy P., Lagarde M. The influence of low intake of n-3 fatty acids on platelets in elderly people. Atherosclerosis 1999, 147:187-192.
61. Kinsella J.E., Lokesh B., Stone R.A. Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms. Am. J. Clin. Nutr. 1990, 52:1-28.
62. Corey E.J., Shih C., Cashman J.R. Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc. Natl. Acad. Sci. 1983, 80:3581-3587.
63. Swann P.G., Venton D.L., Le Breton G.C. Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets. FEBS 1989, 243:244-247.
64. Akiba S., Muata T., Kitatani K., Sato T. Involvement of lipoxygenase pathway in docosapentaenoic acid-induced inhibition of platelet aggregation. Biol. Pharm. Bull. 2000, 23(11):1293-1297.
65. Mann N.J., O'Connell S.L., Baldwin K.M., Singh I., Meyer B.J. Effects of seal oil and tuna-fish oil on platelet parameters and plasma lipid levels in healthy subjects. Lipids 2010, 45:669-681.
66. World Health Organisation, Joint WHO/FAO expert consultation on diet, nutrition and the prevention of chronic diseases, WHO technical report series no 916, Geneva WHO available from: http://www.who.int/nut/documents/trs_916.pdf.
67. Health Council of the Netherlands, Guidelines for a healthy diet, 2006, (accessed 31st August 2010). http://www.gezondheidsraad.nl/sites/default/files/200621E_0.pdf.
68. National Heart Foundation of Australia, Position statement, Fish, fish oils, n-3 polyunsaturated fatty acids and cardiovascular health, National Heart Foundation of Australia, 2008.
69. American Heart Association Nutrition Committee, Lichtenstein A.H., Appel L.J., Brands M., et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006, 114:82-96.
70. American Dietetic Association Position of the American Dietetic Association and Dietitians of Canada: dietary fatty acids, J. Am. Diet. Assoc., vol. 107, 2007, pp. 1599-1611.
71. Backer G., Ambrosioni E., Borch-Johnsen K., et al. European guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 2003, 24:1601-1610.
72. Superior Health Council Belgium Advisory Report: Recommendations and Claims Made on Omega-3 Fatty Acids, 2004, http://www.health.belgium.be/internet2Prd/groups/public/@public/@shc/documents/ie2divers/4492395.pdf%20accessed%202/9/2010.
73. Martin A. Apports Nutritionals Conseilles Pour la Population Francaise 2001, Lavoisier, Paris. third ed.
74. National Health and Medical Research Council, Nutrient Reference Values for Australia and New Zealand including Recommended Dietary Intakes, Australian Government Department of Health and Ageing, 2006.
75. Kris-Etherton P.M., Harris W.S., Appel L.J. American Heart Association, Nutrition Committee, fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747-2757.
76. Verbeke W., Vackier I. Individual determinants of fish consumption: application of the theory of planned behaviour. Appetite 2005, 44:67-82.
77. Harris W.S., von Schacky C. The omega-3 index: a new risk factor for death from coronary heart disease?. Prev. Med. 2004, 39:212-220.
78. Murphy K., Meyer B.J., Mori T.A., et al. Impact of foods enriched with omega-3 long chain polyunsaturated fatty acids on erythrocyte omega-3 levels and cardiovascular risk factors. Br. J. Nutr. 2007, 97:749-757.
79. F. Fayet, B.J. Meyer, K. Baghurst, Four dietary models using fish, lean red meat and LC n-3 PUFA enriched foods are able to meet national dietary recommendations for LC n-3 PUFA, in: Proceedings of the International Seafood and Health Conference, Melbourne 8-10 November, 2010.